Akero Therapeutics (AKRO) PT Lowered to $38 at Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Josh Schimmer lowered the price target on Akero Therapeutics (NASDAQ: AKRO) to $38.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
